Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CIAO1 loss of function causes a neuromuscular disorder with compromise of nucleocytoplasmic Fe-S enzymes
Nunziata Maio, Rotem Orbach, Irina T. Zaharieva, Ana Töpf, Sandra Donkervoort, Pinki Munot, Juliane Mueller, Tracey Willis, Sumit Verma, Stojan Peric, Deepa Krishnakumar, Sniya Sudhakar, A. Reghan Foley, Sarah Silverstein, Ganka Douglas, Lynn Pais, Stephanie DiTroia, Christopher Grunseich, Ying Hu, Caroline Sewry, Anna Sarkozy, Volker Straub, Francesco Muntoni, Tracey A. Rouault, Carsten G. Bönnemann
Nunziata Maio, Rotem Orbach, Irina T. Zaharieva, Ana Töpf, Sandra Donkervoort, Pinki Munot, Juliane Mueller, Tracey Willis, Sumit Verma, Stojan Peric, Deepa Krishnakumar, Sniya Sudhakar, A. Reghan Foley, Sarah Silverstein, Ganka Douglas, Lynn Pais, Stephanie DiTroia, Christopher Grunseich, Ying Hu, Caroline Sewry, Anna Sarkozy, Volker Straub, Francesco Muntoni, Tracey A. Rouault, Carsten G. Bönnemann
View: Text | PDF
Research Article Metabolism Muscle biology

CIAO1 loss of function causes a neuromuscular disorder with compromise of nucleocytoplasmic Fe-S enzymes

  • Text
  • PDF
Abstract

Cytoplasmic and nuclear iron-sulfur (Fe-S) enzymes that are essential for genome maintenance and replication depend on the cytoplasmic Fe-S assembly (CIA) machinery for cluster acquisition. The core of the CIA machinery consists of a complex of CIAO1, MMS19 and FAM96B. The physiological consequences of loss of function in the components of the CIA pathway have thus far remained uncharacterized. Our study revealed that patients with biallelic loss of function in CIAO1 developed proximal and axial muscle weakness, fluctuating creatine kinase elevation, and respiratory insufficiency. In addition, they presented with CNS symptoms including learning difficulties and neurobehavioral comorbidities, along with iron deposition in deep brain nuclei, mild normocytic to macrocytic anemia, and gastrointestinal symptoms. Mutational analysis revealed reduced stability of the variants compared with WT CIAO1. Functional assays demonstrated failure of the variants identified in patients to recruit Fe-S recipient proteins, resulting in compromised activities of DNA helicases, polymerases, and repair enzymes that rely on the CIA complex to acquire their Fe-S cofactors. Lentivirus-mediated restoration of CIAO1 expression reversed all patient-derived cellular abnormalities. Our study identifies CIAO1 as a human disease gene and provides insights into the broader implications of the cytosolic Fe-S assembly pathway in human health and disease.

Authors

Nunziata Maio, Rotem Orbach, Irina T. Zaharieva, Ana Töpf, Sandra Donkervoort, Pinki Munot, Juliane Mueller, Tracey Willis, Sumit Verma, Stojan Peric, Deepa Krishnakumar, Sniya Sudhakar, A. Reghan Foley, Sarah Silverstein, Ganka Douglas, Lynn Pais, Stephanie DiTroia, Christopher Grunseich, Ying Hu, Caroline Sewry, Anna Sarkozy, Volker Straub, Francesco Muntoni, Tracey A. Rouault, Carsten G. Bönnemann

×

Figure 5

Lentivirus-mediated transduction of V5-tagged WT CIAO1 in patient-derived cells reversed all the abnormalities caused by impaired function of the CIA machinery.

Options: View larger image (or click on image) Download as PowerPoint
Lentivirus-mediated transduction of V5-tagged WT CIAO1 in patient-derive...
(A) IBs to detect CIAO1, MMS19, FAM96B, FAM96A, and recipient Fe-S proteins (DPYD, CDKAL1, POLD1, RTEL1, ERCC2, and ELP3) on lysates from P1-derived (CIAO1–/–), parent-derived (CIAO1+/–), and control-derived (CTRL, CIAO1+/+) fibroblasts and from P1-derived fibroblasts after lentivirus-mediated restoration of WT CIAO1 (CIAO1-V5) (n = 4 biological replicates). (B) Representative 55Fe incorporation into POLD1-FLAG/MYC transiently expressed in P1-derived, parent-derived, and control-derived (FC2-derived) fibroblasts and in P1-derived fibroblasts after lentivirus-mediated restoration of WT CIAO1 (CIAO1-V5). Anti-FLAG IB shows that equal amounts of POLD1-F/M were immunoprecipitated (n = 4 biological replicates). (C) Quantification of radioactive iron incorporated into POLD1-F/M as assessed by scintillation counter. [55Fe]-POLD1-F/M levels in control cells (father of P1) were quantified and set to 100%. Values are expressed as a percentage of control and are given as the mean ± SEM. ****P < 0.0001 by 1-way ANOVA Šidák’s multiple-comparison test for P1 versus the father, P1 versus the mother, and P1 versus P1_CIAO1-V5. n = 4 biological replicates. (D) Top section: schematic representation of the reaction catalyzed by the cytosolic Fe-S enzyme DPYD. Bottom section: DPYD-mediated conversion of [4-14C]-thymine to [4-14C]-dihydrothymine in lysates derived from P1, parental, or control fibroblasts (representing a fibroblast cell line harboring 2 WT copies of CIAO1, CTRL), and in P1- derived fibroblasts stably expressing CIAO1-V5, as indicated, assayed by TLC and autoradiography. The reaction mix containing the substrate of the reaction, [4-14C]-T without cell extract, was loaded as a negative control (no extract) to visualize the substrate (4-14C-thymine) by TLC (n = 3 biological replicates).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts